Eric A. Adams - 23 Dec 2023 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INM	Employee Stock Option (Right to Buy)	Award	$0	+136,000	+520%	$0.000000	162,139	23 Dec 2023	Common shares	136,000	$0.3700	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month).